Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98(3):641–653

Baker PR et al (2014) Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. Br J Neurol 137(2):366–379

Beart PM, O’shea RD (2007) Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150(1):5–17

Brennan AM et al (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 12:857–863

Brown GC (2010) Nitric oxide and neuronal death. Nitric oxide: Biology and Chemistry 23(3):153–165

Busanello ENB et al (2010) Neurochemical evidence that glycine induces bioenergetical dysfunction. Neurochem Int 56:948–954

Choi DW, Excitotoxicity (2020) Still Hammering the Ischemic Brain in 2020. Front Neurosci 14:579953

Dinuzzo M et al (2014) Physiological bases of the K + and the glutamate/GABA hypotheses of epilepsy. Epilepsy Res 108(6):995–1012

Duchen MR (2012) Mitochondria, calcium-dependent neuronal death and neurodegenerative disease. Pflugers Arch European J Physiol 464(1):111–121

Görlach A et al (2015) Calcium and ROS: A mutual interplay. Redox Biol 6:260–271

Greene JG, Greenamyre JT (1996) Bioenergetics and glutamate excitotoxicity. Prog Neurobiol 48(6):613–634

Guan ZZ (2008) Cross-talk between oxidative stress and modifications of cholinergic and glutaminergic receptors in the pathogenesis of Alzheimer’s disease. Acta Pharmacol Sin 29(7):773–780

Article  CAS  PubMed  Google Scholar 

Halliwell B, Gutteridge JMC (2015) Free Radicals in Biology and Medicine. 5th Edition, Oxford University Press, New York

Hamosh A, Johnston MV (2001) Non-ketotic hyperglycinemia. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 2065–2078

Google Scholar 

Hardingham G (2019) NMDA receptor C-terminal signaling in development, plasticity, and disease. F1000Research 8: F1000 Faculty Rev-1547

Hennermann JB et al (2012) Prediction of long-term outcome in glycine encephalopathy: a clinical survey. J Inherit Metabolic Disease 35(2):253–261

Hoover-Fong JE et al (2004) Natural history of nonketotic hyperglycinemia in 65 patients. Neurology 63(10):847–1853

Jones DP (2006) Redefining oxidative stress. Antioxid Redox Signal 8(9–10):1865–1879

Lau A, Tymianski M (2010) Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch European J Physiol 460(2):525–542

Leipnitz G et al (2009) Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats. Cell Mol Neurobiol 29(2):253–261

Liu W et al (2023) The role of N-methyl-D-aspartate glutamate receptors in Alzheimer’s disease: From pathophysiology to therapeutic approaches. Prog Neurobiol 231:102534

Michaelis EK (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 54(4):369–415

Moura AP et al (2014) Evidence that glycine induces lipid peroxidation and decreases glutathione concentrations in rat cerebellum. Mol Cell Biochem 395(1–2):125–134

Moura AP et al (2013) Glycine intracerebroventricular administration disrupts mitochondrial energy homeostasis in cerebral cortex and striatum of young rats. Neurotox Res 24(4):502–511

Moura AP et al (2016) Intracerebral Glycine Administration Impairs Energy and Redox Homeostasis and induces glial reactivity in cerebral cortex of newborn rats. Mol Neurobiol 53(9):5864–5875

Nakamura T et al (2010) S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration. Mitochondrion 10(5):573–578

Nowak M, Chuchra P, Paprocka J (2022) Nonketotic hyperglycinemia: insight into current therapies. J Clin Med 11(11):3027

Ohya Y et al (1991) Nonketotic hyperglycinemia: treatment with NMDA antagonist and consideration of neuropathogenesis. Pediatr Neurol 7(1):65–68

Paoletti et al (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14(6):383–400

Parmeggiani B et al (2019) Bezafibrate prevents Glycine-Induced increase of antioxidant enzyme activities in Rat Striatum. Mol Neurobiol 56(1):29–38

Parmeggiani B et al (2023) Glycine disrupts myelin, glutamatergic neurotransmission, and redox homeostasis in a neonatal model for non ketotic hyperglycinemia. Biochimie 219:21–32

Piniella D, Zafra F (2023) Functional crosstalk of the glycine transporter GlyT1 and NMDA receptors. Neuropharmacol 232:109514

Puurand M et al (2018) Intracellular Energy-Transfer Networks and High-Resolution Respirometry: A Convenient Approach for Studying Their Function. Int J Mol Sci 19(10):2933

Riché R et al (2018) Glycine decarboxylase deficiency–induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level. JCI Insight 3(21):e124642

Seminotti B et al (2011) Glycine intrastriatal administration induces lipid and protein oxidative damage and alters the enzymatic antioxidant defenses in rat brain. Life Sci 89:7–8 

Google Scholar 

Sies H (2014) Role of metabolic H2O2 generation: redox signaling and oxidative stress. J Biol Chem 289:8735–8741

Stence NV et al (2019) Brain imaging in classic nonketotic hyperglycinemia: Quantitative analysis and relation to phenotype. J Inherit Metab Dis 42(3): 438–450

Stroebel D, Mony l, Paoletti P (2021) Glycine agonism in ionotropic glutamate receptors. Neuropharmacology 193:108631

Swanson MA et al (2015) Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Ann Neurol 78(4):606–618

Tena-Morraja P et al (2023) Synaptic activity regulates mitochondrial Iron metabolism to enhance neuronal bioenergetics. Int J Mol Sci 24(2):922

Traynelis SF et al (2010) Glutamate Receptor Ion Channels: Structure, Regulation, and Function. Pharmacol Rev 62(3):405–496

Van Hove JLK, Coughlin CII, Swanson M, Hennermann JB, Nonketotic Hyperglycinemia (2002) Nov 14 [updated 2019 May 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023

Verma M, Lizama BN, Chu CT (2022) Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener 11(1):3

Vyklicky V et al (2014) Structure, function, and pharmacology of NMDA receptor channels. Physiol Res 63(1):S191–203

Wang W et al (2015) MFN2 couples glutamate excitotoxicity and mitochondrial dysfunction in motor neurons. J Biol Chem 290(1):168–182